Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Iavarone

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Oncology Research|April 3, 2026
The Effect of Metformin on Atezolizumab/Bevacizumab Treatment in Patients with Hepatocellular Carcinoma and DiabetesAndrea Dalbeni, Marco Vicardi, Leonardo A Natola, et al.
The Lancet. Oncology|July 3, 2020
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trialVincenzo Mazzaferro, Davide Citterio, Sherrie Bhoori, et al.
Liver Cancer|December 24, 2025
Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic TherapyCamilla De Carlo, Reha Akpinar, Barbara Durante, et al.
Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Cancer Management and Research|January 7, 2022
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in ItalyValentina Burgio, Massimo Iavarone, Giovanni Giuseppe Di Costanzo, et al.
Scientific Reports|August 30, 2024
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus BevacizumabMargherita Rimini, Margarida Montes, Elisabeth Amadeo, et al.
Journal of Hepatology|October 20, 2023
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipientsSam M Murray, Elisa Pose, Melanie Wittner, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2021
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective StudyMassimo Iavarone, Federica Invernizzi, Tommy Ivanics, et al.
Liver Cancer|May 16, 2024
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in LenvatinibMassimo Iavarone, Eleonora Alimenti, Toshifumi Tada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2026
Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE ScoreLorenzo Canova, Eleonora Alimenti, Lorenzo Argiento, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Oncology Research|April 3, 2026
The Effect of Metformin on Atezolizumab/Bevacizumab Treatment in Patients with Hepatocellular Carcinoma and DiabetesAndrea Dalbeni, Marco Vicardi, Leonardo A Natola, et al.
The Lancet. Oncology|July 3, 2020
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trialVincenzo Mazzaferro, Davide Citterio, Sherrie Bhoori, et al.
Liver Cancer|December 24, 2025
Vessels That Encapsulate Tumor Cluster+ Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic TherapyCamilla De Carlo, Reha Akpinar, Barbara Durante, et al.
Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.
Cancer Management and Research|January 7, 2022
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in ItalyValentina Burgio, Massimo Iavarone, Giovanni Giuseppe Di Costanzo, et al.
Scientific Reports|August 30, 2024
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus BevacizumabMargherita Rimini, Margarida Montes, Elisabeth Amadeo, et al.
Journal of Hepatology|October 20, 2023
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipientsSam M Murray, Elisa Pose, Melanie Wittner, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2021
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective StudyMassimo Iavarone, Federica Invernizzi, Tommy Ivanics, et al.
Liver Cancer|May 16, 2024
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in LenvatinibMassimo Iavarone, Eleonora Alimenti, Toshifumi Tada, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2026
Predicting decompensation in unresectable hepatocellular carcinoma on atezolizumab plus bevacizumab: the ARTE ScoreLorenzo Canova, Eleonora Alimenti, Lorenzo Argiento, et al.
Pageof 15